HuGE Literature Finder
Records
1
-
11
| Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis. Medicine 2021 Mar 100 (12): e25078. Liu Linlin, Sun Xu, Yuan Chenxi, Liu Huaim |
| Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso. Open life sciences 2021 10 16 (1): 1101-1110. Zouré Abdou Azaque, Amegnona Lanyo Jospin, Zongo Nayi, Kiendrebeogo Isabelle Touwendpoulimdé, Sorgho Pegdwendé Abel, Zongo Fabienne Ingrid, Yonli Albert Théophane, Sombié Herman Karim, Bambara Aboubacar Hierrhum, Sawadogo Alexis Yobi, Ouedraogo Marie N L, Traoré Lassina, Zongo Sidnooma Véronique, Lallogo Doriane Tatiana, Bazié Bapio Valery Jean Télesphore Elvira, Zohoncon Théodora M, Dijgma Florencia W, Simpore Jacqu |
| Breast Cancer Is Associated with Increased HLA-DRB1*11:01 and HLA-DRB1*10:01 Allele Frequency in a Population of Patients from Central Italy. Immunological investigations 2020 3 49 (5): 489-497. Aureli Anna, Canossi Angelica, Del Beato Tiziana, Buonomo Oreste, Rossi Piero, Roselli Mario, Papola Franco, Marziani Beatrice, Sconocchia Giusep |
| Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. The pharmacogenomics journal 2017 8 18 (3): 480-486. Spraggs C F, Parham L R, Briley L P, Warren L, Williams L S, Fraser D J, Jiang Z, Aziz Z, Ahmed S, Demetriou G, Mehta A, Jackson N, Byrne J, Andersson M, Toi M, Harris L, Gralow J, Zujewski J A, Crescenzo R, Armour A, Perez E, Piccart |
| Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Aug 32 (22): 2296-303. Schaid Daniel J, Spraggs Colin F, McDonnell Shannon K, Parham Laura R, Cox Charles J, Ejlertsen Bent, Finkelstein Dianne M, Rappold Erica, Curran Joan, Cardon Lon R, Goss Paul |
| Negative association of the HLA-DQB1*02 allele with breast cancer development among Jordanians. Asian Pacific journal of cancer prevention : APJCP 2013 14 (11): 7007-10. Atoum Manar Fayiz, Tanashat Reem Qasem, Mahmoud Sameer Al H |
| HLA class-II allele frequencies in Turkish breast cancer patients. Medical oncology (Northwood, London, England) 2012 Jun 29 (2): 466-71. Gun Faik Deniz, Ozturk Ozlem Goruroglu, Polat Ayse, Polat Gurb |
| HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer. Pathology oncology research : POR 2012 Jan 18 (1): 49-55. Mahmoodi Majid, Nahvi Hedayat, Mahmoudi Mahdi, Kasaian Amir, Mohagheghi Mohammad-Ali, Divsalar Kouros, Nahavandian Bijan, Jafari Abbas, Ansarpour Bita, Moradi Batoul, Aghamohammadi Asghar, Amirzargar Aliakb |
| HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia? Pathology oncology research : POR 2006 12 (2): 79-81. Baccar Harrath Amal, Yacoubi Loueslati Besma, Troudi Wafa, Hmida Slama, Sedkaoui Syrine, Dridi Amel, Jridi Afef, Ben Ayed Farhat, Ben Rhomdhane Khaled, Ben Ammar Elgaaied Am |
| HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathology oncology research : POR 2001 7 (1): 39-41. Ghaderi A, Talei A, Gharesi-Fard B, Farjadian S H, Amirzargar A, Vasei |
| Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proceedings of the National Academy of Sciences of the United States of America 2000 Oct 97 (21): 11451-4. Chaudhuri S, Cariappa A, Tang M, Bell D, Haber D A, Isselbacher K J, Finkelstein D, Forcione D, Pillai |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: